Andere Sprachen Alpha Cognition Inc. Toronto S.E.

Aktien

A3CNL7

CA02074J2048

ACOG

Schlusskurs Toronto S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^CAD	-.--%		-.--%	-.--%

04.04.	Alpha Cognition's Q4 Comprehensive Loss weitet sich im Vergleich zum Vorjahreszeitraum etwas aus	MT
04.04.	Alpha Cognition Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04.04.
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04.04.
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01.03.
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22.02.
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22.02.
Alpha Cognition Provides Business Update	12.02.
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	19.01.
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19.01.
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	22.12.
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08.12.
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	07.12.
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	07.12.
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05.12.
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05.12.
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28.11.
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	08.11.
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	16.10.23
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	02.10.23
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	27.09.23
Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering	01.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Alpha Cognition Inc. Toronto S.E.

Aktien

A3CNL7

CA02074J2048

ACOG

Andere Sprachen

Filter